New Edge Advisors, LLC Optimize Rx Corp Transaction History

New Edge Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$13.77 - $22.04 $7,559 - $12,099	549 New	549 $9,000
Q2 2022 Aug 09, 2022	BUY	$21.94 - $40.49 $222,164 - $410,001	10,126 Added 52.26%	29,502 $808,000
Q1 2022 May 13, 2022	BUY	$35.27 - $62.91 $284,769 - $507,935	8,074 Added 71.44%	19,376 $731,000
Q4 2021 Feb 17, 2022	SELL	$53.57 - $98.0 $109,175 - $199,724	-2,038 Reduced 15.28%	11,302 $702,000
Q3 2021 Oct 29, 2021	SELL	$50.93 - $85.55 $118,972 - $199,844	-2,336 Reduced 14.9%	13,340 $1.14 Million

Q2 2021 Jul 22, 2021	BUY	$42.76 - $63.33 $670,305 - $992,761	15,676 New	15,676 $970,000

101

12.9M

18.6K

1.1K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $180M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.